2015 World STI & HIV Congress and Australasian HIV&AIDS Conference

Professor Suzanne Garland is a regular advisor to the World Health Organisation on sexual and reproductive health infections, cervical cancer and human papillomavirus (HPV).  She has been a chief investigator for phase 3, clinical HPV vaccine trials for both the bivalent and quadrivalent vaccines and is currently measuring vaccine effectiveness post the vaccine rollout in Australia.  Professor Garland was integral to the set up of the New Society Asia Oceania Research Organisation on Genital Infections and Neoplasia (AOGIN).  She is the Inaugural and Past President of this Society and ongoing Board Advisor.  With a special interest in the management of herpes in pregnant women and neonates, Professor Garland Chairs the Obstetrics and Gynaecological working group of the Australian Herpes Management Forum of which she is a Board Member, GBS.  She is currently the Clinical Director of Microbiology and Infectious Diseases at the Women’s, Director of Microbiology Research at the Women’s, and Senior Consultant in Microbiology at The Royal Children’s Hospital.